Asked by: Edward Morello (Liberal Democrat - West Dorset)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what measures are in place to prevent CHC funding reductions from compromising care for vulnerable patients in West Dorset constituency.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department and NHS England have made clear that any work to manage costs by integrated care boards (ICB) must be carried out with clear safeguards in place to protect frontline responsibilities.
ICBs remain legally responsible for the operational delivery of NHS Continuing Healthcare (CHC) and must have regard to the National Framework for NHS Continuing Healthcare and NHS-funded Nursing Care, which is available at the following link:
Funding for CHC is not ringfenced, but is calculated using the ICB allocation formula. Individual ICBs should decide how best to use their overall funding allocation to deliver their statutory functions, including CHC. Any ICB measures to manage costs should not impact on an individual’s eligibility for CHC, or their care. This means that eligible individuals must continue to receive appropriate care that meets their assessed needs.
NHS England has issued a good practice guide for CHC to support National Health Service staff by providing practical ways for ICBs to enhance system efficiency and deliver sustainable services.
Asked by: Edward Morello (Liberal Democrat - West Dorset)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that CHC funding cuts do not reduce access to care in West Dorset constituency.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department and NHS England have made clear that any work to manage costs by integrated care boards (ICB) must be carried out with clear safeguards in place to protect frontline responsibilities.
ICBs remain legally responsible for the operational delivery of NHS Continuing Healthcare (CHC) and must have regard to the National Framework for NHS Continuing Healthcare and NHS-funded Nursing Care, which is available at the following link:
Funding for CHC is not ringfenced, but is calculated using the ICB allocation formula. Individual ICBs should decide how best to use their overall funding allocation to deliver their statutory functions, including CHC. Any ICB measures to manage costs should not impact on an individual’s eligibility for CHC, or their care. This means that eligible individuals must continue to receive appropriate care that meets their assessed needs.
NHS England has issued a good practice guide for CHC to support National Health Service staff by providing practical ways for ICBs to enhance system efficiency and deliver sustainable services.
Asked by: Edward Morello (Liberal Democrat - West Dorset)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how his Department is supporting NHS staff who may be adversely affected by CHC funding reductions.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department and NHS England have made clear that any work to manage costs by integrated care boards (ICB) must be carried out with clear safeguards in place to protect frontline responsibilities.
ICBs remain legally responsible for the operational delivery of NHS Continuing Healthcare (CHC) and must have regard to the National Framework for NHS Continuing Healthcare and NHS-funded Nursing Care, which is available at the following link:
Funding for CHC is not ringfenced, but is calculated using the ICB allocation formula. Individual ICBs should decide how best to use their overall funding allocation to deliver their statutory functions, including CHC. Any ICB measures to manage costs should not impact on an individual’s eligibility for CHC, or their care. This means that eligible individuals must continue to receive appropriate care that meets their assessed needs.
NHS England has issued a good practice guide for CHC to support National Health Service staff by providing practical ways for ICBs to enhance system efficiency and deliver sustainable services.
Asked by: Edward Morello (Liberal Democrat - West Dorset)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of cuts to Continuing Healthcare funding on patient care.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department and NHS England have made clear that any work to manage costs by integrated care boards (ICB) must be carried out with clear safeguards in place to protect frontline responsibilities.
ICBs remain legally responsible for the operational delivery of NHS Continuing Healthcare (CHC) and must have regard to the National Framework for NHS Continuing Healthcare and NHS-funded Nursing Care, which is available at the following link:
Funding for CHC is not ringfenced, but is calculated using the ICB allocation formula. Individual ICBs should decide how best to use their overall funding allocation to deliver their statutory functions, including CHC. Any ICB measures to manage costs should not impact on an individual’s eligibility for CHC, or their care. This means that eligible individuals must continue to receive appropriate care that meets their assessed needs.
NHS England has issued a good practice guide for CHC to support National Health Service staff by providing practical ways for ICBs to enhance system efficiency and deliver sustainable services.
Asked by: Edward Morello (Liberal Democrat - West Dorset)
Question to the Department for Education:
To ask the Secretary of State for Education, what assessment her Department has made of trends in the level of progression rates from foundation to other low-level courses in colleges in the South West.
Answered by Josh MacAlister - Parliamentary Under-Secretary (Department for Education)
Progression rates for further education achievers aged 16+ at Below Level 2 and Essential Skills into sustained further learning (by level of learning destination) between 2018/19 and 2022/23 in i) England, ii) Dorset and iii) the South West are shown in the following tables:
The department does not publish data on employment outcomes for learners progressing to other lower-level learning from foundation courses, but it does publish sustained employment outcome rates for learners achieving at Below Level 2 and in Essential Skills between 2018/19 and 2022/23 in England, as shown in the following table: https://explore-education-statistics.service.gov.uk/data-tables/permalink/aa7ce8db-5a14-4898-4a4c-08de398c3998.
These statistics are available in the ‘Further education outcomes’ publication. This answer is based on the latest statistics that were released on 18 December 2025 and can be found here: https://explore-education-statistics.service.gov.uk/find-statistics/further-education-outcomes/2022-23. The next update to this series will be published in November 2026.
Asked by: Edward Morello (Liberal Democrat - West Dorset)
Question to the Department for Education:
To ask the Secretary of State for Education, what assessment she has made of trends in the level of (a) national progression rates from foundation to other low-level courses in colleges and (b) employment outcomes from those rates.
Answered by Josh MacAlister - Parliamentary Under-Secretary (Department for Education)
Progression rates for further education achievers aged 16+ at Below Level 2 and Essential Skills into sustained further learning (by level of learning destination) between 2018/19 and 2022/23 in i) England, ii) Dorset and iii) the South West are shown in the following tables:
The department does not publish data on employment outcomes for learners progressing to other lower-level learning from foundation courses, but it does publish sustained employment outcome rates for learners achieving at Below Level 2 and in Essential Skills between 2018/19 and 2022/23 in England, as shown in the following table: https://explore-education-statistics.service.gov.uk/data-tables/permalink/aa7ce8db-5a14-4898-4a4c-08de398c3998.
These statistics are available in the ‘Further education outcomes’ publication. This answer is based on the latest statistics that were released on 18 December 2025 and can be found here: https://explore-education-statistics.service.gov.uk/find-statistics/further-education-outcomes/2022-23. The next update to this series will be published in November 2026.
Asked by: Edward Morello (Liberal Democrat - West Dorset)
Question to the Department for Education:
To ask the Secretary of State for Education, how many and what proportion of students progress from foundation to other low-level courses in colleges in Dorset.
Answered by Josh MacAlister - Parliamentary Under-Secretary (Department for Education)
Progression rates for further education achievers aged 16+ at Below Level 2 and Essential Skills into sustained further learning (by level of learning destination) between 2018/19 and 2022/23 in i) England, ii) Dorset and iii) the South West are shown in the following tables:
The department does not publish data on employment outcomes for learners progressing to other lower-level learning from foundation courses, but it does publish sustained employment outcome rates for learners achieving at Below Level 2 and in Essential Skills between 2018/19 and 2022/23 in England, as shown in the following table: https://explore-education-statistics.service.gov.uk/data-tables/permalink/aa7ce8db-5a14-4898-4a4c-08de398c3998.
These statistics are available in the ‘Further education outcomes’ publication. This answer is based on the latest statistics that were released on 18 December 2025 and can be found here: https://explore-education-statistics.service.gov.uk/find-statistics/further-education-outcomes/2022-23. The next update to this series will be published in November 2026.
Asked by: Edward Morello (Liberal Democrat - West Dorset)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will extend the eligibility for free Covid vaccines to people with Respiratory Syncytial Virus in West Dorset constituency.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to protecting those most vulnerable to COVID-19 and the respiratory syncytial virus (RSV) through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI). The primary aim of the national COVID-19 and RSV vaccination programmes is the prevention of serious illness, resulting in hospitalisations and deaths.
Although RSV and COVID-19 can both cause severe disease, they differ in their epidemiology and pathology. As such, the population groups at higher risk of severe disease will not necessarily be the same for each pathogen.
The JCVI has advised that population immunity to COVID-19 has been increasing due to a combination of naturally acquired immunity, following recovery from infection, and vaccine-derived immunity. COVID-19 is now a relatively mild disease for most people, though it can still be unpleasant, with rates of hospitalisation and death from COVID-19 having reduced significantly since COVID-19 first emerged.
The focus of the JCVI advised programme has moved towards targeted vaccination of the two groups who continue to be at higher risk of serious disease, including mortality. These are the oldest adults and individuals who are immunosuppressed.
The Government accepted the JCVI advice for autumn 2025 and in line with the advice, a COVID-19 vaccination is being offered to the following groups:
- adults aged 75 years old and over;
- residents in care homes for older adults;
- individuals aged six months and over who are immunosuppressed.
In line with JCVI advice, RSV vaccination programmes were introduced in England in September 2024 to protect infants, via maternal vaccination, and older adults at greatest risk of harm from RSV infection.
As for all vaccination programmes, the JCVI keeps the evidence under regular review.
Asked by: Edward Morello (Liberal Democrat - West Dorset)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment has he made of the potential benefits of increasing eligibility for free Covid vaccines to people with Respiratory Syncytial Virus in West Dorset constituency.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to protecting those most vulnerable to COVID-19 and the respiratory syncytial virus (RSV) through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI). The primary aim of the national COVID-19 and RSV vaccination programmes is the prevention of serious illness, resulting in hospitalisations and deaths.
Although RSV and COVID-19 can both cause severe disease, they differ in their epidemiology and pathology. As such, the population groups at higher risk of severe disease will not necessarily be the same for each pathogen.
The JCVI has advised that population immunity to COVID-19 has been increasing due to a combination of naturally acquired immunity, following recovery from infection, and vaccine-derived immunity. COVID-19 is now a relatively mild disease for most people, though it can still be unpleasant, with rates of hospitalisation and death from COVID-19 having reduced significantly since COVID-19 first emerged.
The focus of the JCVI advised programme has moved towards targeted vaccination of the two groups who continue to be at higher risk of serious disease, including mortality. These are the oldest adults and individuals who are immunosuppressed.
The Government accepted the JCVI advice for autumn 2025 and in line with the advice, a COVID-19 vaccination is being offered to the following groups:
- adults aged 75 years old and over;
- residents in care homes for older adults;
- individuals aged six months and over who are immunosuppressed.
In line with JCVI advice, RSV vaccination programmes were introduced in England in September 2024 to protect infants, via maternal vaccination, and older adults at greatest risk of harm from RSV infection.
As for all vaccination programmes, the JCVI keeps the evidence under regular review.
Asked by: Edward Morello (Liberal Democrat - West Dorset)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment has he made of the potential benefits of increasing eligibility for free Covid vaccines to people with Respiratory Syncytial Virus.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to protecting those most vulnerable to COVID-19 and the respiratory syncytial virus (RSV) through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI). The primary aim of the national COVID-19 and RSV vaccination programmes is the prevention of serious illness, resulting in hospitalisations and deaths.
Although RSV and COVID-19 can both cause severe disease, they differ in their epidemiology and pathology. As such, the population groups at higher risk of severe disease will not necessarily be the same for each pathogen.
The JCVI has advised that population immunity to COVID-19 has been increasing due to a combination of naturally acquired immunity, following recovery from infection, and vaccine-derived immunity. COVID-19 is now a relatively mild disease for most people, though it can still be unpleasant, with rates of hospitalisation and death from COVID-19 having reduced significantly since COVID-19 first emerged.
The focus of the JCVI advised programme has moved towards targeted vaccination of the two groups who continue to be at higher risk of serious disease, including mortality. These are the oldest adults and individuals who are immunosuppressed.
The Government accepted the JCVI advice for autumn 2025 and in line with the advice, a COVID-19 vaccination is being offered to the following groups:
- adults aged 75 years old and over;
- residents in care homes for older adults;
- individuals aged six months and over who are immunosuppressed.
In line with JCVI advice, RSV vaccination programmes were introduced in England in September 2024 to protect infants, via maternal vaccination, and older adults at greatest risk of harm from RSV infection.
As for all vaccination programmes, the JCVI keeps the evidence under regular review.